Literature DB >> 15114607

Human herpesvirus 8 (HHV-8)-associated peritoneal primary effusion lymphoma (PEL) in two HIV-negative elderly patients.

Emmanuelle Boulanger1, Olivier Hermine, Jean-Paul Fermand, Isabelle Radford-Weiss, Nicole Brousse, Véronique Meignin, Antoine Gessain.   

Abstract

Human herpesvirus 8 (KSHV/HHV-8) is associated with all forms of Kaposi sarcoma (KS), with a rare high-grade B-cell non-Hodgkin lymphoma characterized by serous effusions in body cavities called primary effusion lymphoma (PEL) and with some forms of multicentric Castleman disease (MCD). Although mostly observed during AIDS, such disorders have also been described with a lower incidence in human immunodeficiency virus-negative patients. We describe here the features of two novel cases of AIDS-unrelated PEL. Two patients, a 78-year-old man (case 1) and a 86-year-old woman (case 2), both of French origin, presented exudative ascitic effusion containing numerous KSHV/HHV-8(+) EBV(-) large lymphomatous cells of B-cell clonal origin, characterized by a CD45(+) CD30(+) CD19(-) CD20(-) immunophenotype. The PEL tumor cells harbored a homogenous and isolated trisomy 12 in case 1 and an aberrant expression of the T-cell lineage antigen CD7 in case 2. Both patients were lymphopenic at the time of PEL diagnosis and rapidly died with progressive lymphoma. Moreover, patient 2 had a previous history of classic KS and MCD clinically improved after treatment with all-trans-retinoid acid and a concomitant metastatic breast adenocarcinoma. Compared to AIDS-related PEL, these two cases displayed distinct features in particular the advanced age of patients, as observed for Mediterranean KS, and the absence of EBV coinfection. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15114607     DOI: 10.1002/ajh.20048

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  16 in total

1.  Primary effusion lymphoma presenting as a cutaneous intravascular lymphoma.

Authors:  Genevieve M Crane; Rena R Xian; Kathleen H Burns; Michael J Borowitz; Amy S Duffield; Janis M Taube
Journal:  J Cutan Pathol       Date:  2014-12-08       Impact factor: 1.587

2.  HHV-8-positive and EBV-positive intravascular lymphoma: an unusual presentation of extracavitary primary effusion lymphoma.

Authors:  Genevieve M Crane; Richard F Ambinder; Courtney M Shirley; Elliot K Fishman; Yvette L Kasamon; Janis M Taube; Michael J Borowitz; Amy S Duffield
Journal:  Am J Surg Pathol       Date:  2014-03       Impact factor: 6.394

3.  Primary human herpesvirus 8-negative effusion-based lymphoma: a large B-cell lymphoma with favorable prognosis.

Authors:  Daisuke Kaji; Yasunori Ota; Yasuharu Sato; Koji Nagafuji; Yasunori Ueda; Masataka Okamoto; Yasushi Terasaki; Naoko Tsuyama; Kosei Matsue; Tomohiro Kinoshita; Go Yamamoto; Shuichi Taniguchi; Shigeru Chiba; Koichi Ohshima; Koji Izutsu
Journal:  Blood Adv       Date:  2020-09-22

4.  Human herpesvirus-8 infection leads to expansion of the preimmune/natural effector B cell compartment.

Authors:  Silvia Della Bella; Adriano Taddeo; Elena Colombo; Lucia Brambilla; Monica Bellinvia; Fabrizio Pregliasco; Monica Cappelletti; Maria Luisa Calabrò; Maria Luisa Villa
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

Review 5.  HIV infection and lymphoma.

Authors:  K L Grogg; R F Miller; A Dogan
Journal:  J Clin Pathol       Date:  2007-12       Impact factor: 3.411

6.  HHV8/KSHV-Positive Lymphoproliferative Disorders and the Spectrum of Plasmablastic and Plasma Cell Neoplasms: 2015 SH/EAHP Workshop Report-Part 3.

Authors:  Amy Chadburn; Jonathan Said; Dita Gratzinger; John K C Chan; Daphne de Jong; Elaine S Jaffe; Yasodha Natkunam; John R Goodlad
Journal:  Am J Clin Pathol       Date:  2017-02-01       Impact factor: 2.493

7.  Human Immunodeficiency Virus (HIV)-Negative and Human Herpes Virus-8 (HHV-8)-Positive Primary Effusion Lymphoma: A Case Report and Review of the Literature.

Authors:  Sonay Güven Karataş; Reyhan Bayrak; Ozlem Sahin Balçık; Kadir Serkan Yalçın; Esra Atıcı; Umit Akyıldız; Ali Koşar
Journal:  Turk J Haematol       Date:  2013-03-05       Impact factor: 1.831

8.  EBV and HIV-Related Lymphoma.

Authors:  Michele Bibas; Andrea Antinori
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-12-29       Impact factor: 2.576

9.  Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors.

Authors:  B Tolani; R Gopalakrishnan; V Punj; H Matta; P M Chaudhary
Journal:  Oncogene       Date:  2013-06-24       Impact factor: 9.867

10.  An unusual case of Primary Effusion Lymphoma with aberrant T-cell phenotype in a HIV-negative, HBV-positive, cirrhotic patient, and review of the literature.

Authors:  Charitini Nepka; Dimitrios Kanakis; Maria Samara; Andreas Kapsoritakis; Spyridon Potamianos; Maria Karantana; Georgios Koukoulis
Journal:  Cytojournal       Date:  2012-06-29       Impact factor: 2.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.